GATA-4, a potential novel therapeutic target for high-grade meningioma, regulates miR-497, a potential novel circulating biomarker for high-grade meningioma

BACKGROUND: Meningiomas are the most common primary intracranial tumours. They are classified as grade I, II, and III based on their histopathological features. While most meningiomas can be managed by surgery alone, adjuvant treatment may be required in case of recurrent, or high-grade tumours. To...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:EBioMedicine
Main Authors: Negroni, Caterina, Hilton, David A., Ercolano, Emanuela, Adams, Claire L., Kurian, Kathreena M., Baiz, Daniele, Hanemann, C.Oliver
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020
Assuntos:
Research paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7452696/
https://ncbi.nlm.nih.gov/pubmed/32810829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2020.102941
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados